SARASOTA, Fla., June 10 /PRNewswire/ -- The Roskamp Institute (Roskamp) today announced it was awarded the Florida Department of Health and James & Esther King Biomedical Research Program, Small Business Technology Transfer Grant for its advanced cancer research in using B-amyloid protein to stop the growth of lung cancer.
The grant in the amount of $100,000 was awarded to Roskamp’s Investigator Daniel Paris, Ph.D. based on the scientific merit score Roskamp’s proposal received through a competitive and qualified peer review process and the consideration of other factors by the Biomedical Research Advisory Council.
“This grant brings us one step closer to stopping the growth of lung cancer through our continued research with the use of B-amyloid protein,” said Paris. “We are excited to have been awarded this grant, and we look forward to the advances we intend to make through our Institute’s anti-cancer technology.”
The peer-reviewed grant given to Roskamp for the “Treatment of Lung Adenocarcinoma and Metastasis by Anti-angiogenic Fragments of Abeta” project commences on July 1, 2008, and the life of the grant will be overseen by a grant manager of the James & Esther King Biomedical Research Program.
“The James & Esther King Program is known for its highly competitive grant award process, and we are honored to be a recipient,” said Dr. Michael Mullan, director of Roskamp. “As a member of Florida’s research community, we are committed to using this collaborative opportunity with small biomedical businesses and researchers alike to further our research advancements in hopes of curing this devastating disease.”
The Roskamp Institute is a not-for-profit research Institute located in Sarasota and Tampa, Florida, that is dedicated to understanding the causes of, and finding cures for, neuropsychiatric and neurodegenerative disorders and addictions with an emphasis on Alzheimer’s disease. Roskamp’s Memory Centers also offer comprehensive cognitive and medical assessment toward differential diagnosis of Alzheimer’s disease and offers treatments and disease management options once the diagnostic evaluation is complete.
For more information, please contact the Roskamp Institute in Sarasota at (941) 752-2949, the Roskamp Institute Clinical Trials Division in Sarasota at (941) 256-8018, the Roskamp Institute Memory Center in Tampa at (813) 979-2008, or visit us online at http://www.RoskampInstitute.com.
CONTACT: Kristen Bridges, +1-850-222-2140, for Roskamp Institute
Web site: http://www.RoskampInstitute.com/